Weber JS - Search Results

1

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.

Usyk M, Pandey A, Hayes RB, Moran U, Pavlick A, Osman I, Weber JS, Ahn J. Usyk M, et al. Among authors: weber js. Genome Med. 2021 Oct 13;13(1):160. doi: 10.1186/s13073-021-00974-z. Genome Med. 2021. PMID: 34641962 Free PMC article.

2

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Hersh EM, O'Day SJ, Powderly J, Khan KD, Pavlick AC, Cranmer LD, Samlowski WE, Nichol GM, Yellin MJ, Weber JS. Hersh EM, et al. Among authors: weber js. Invest New Drugs. 2011 Jun;29(3):489-98. doi: 10.1007/s10637-009-9376-8. Epub 2010 Jan 16. Invest New Drugs. 2011. PMID: 20082117 Clinical Trial.

3

Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.

Trunzer K, Pavlick AC, Schuchter L, Gonzalez R, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Kim KB, Weber JS, Hersey P, Long GV, Lawrence D, Ott PA, Amaravadi RK, Lewis KD, Puzanov I, Lo RS, Koehler A, Kockx M, Spleiss O, Schell-Steven A, Gilbert HN, Cockey L, Bollag G, Lee RJ, Joe AK, Sosman JA, Ribas A. Trunzer K, et al. Among authors: weber js. J Clin Oncol. 2013 May 10;31(14):1767-74. doi: 10.1200/JCO.2012.44.7888. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569304 Clinical Trial.

4

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Lattanzi M, Lee Y, Simpson D, Moran U, Darvishian F, Kim RH, Hernando E, Polsky D, Hanniford D, Shapiro R, Berman R, Pavlick AC, Wilson MA, Kirchhoff T, Weber JS, Zhong J, Osman I. Lattanzi M, et al. Among authors: weber js. J Natl Cancer Inst. 2019 Feb 1;111(2):180-188. doi: 10.1093/jnci/djy086. J Natl Cancer Inst. 2019. PMID: 29912415 Free PMC article.

5

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.

Rodig SJ, Gusenleitner D, Jackson DG, Gjini E, Giobbie-Hurder A, Jin C, Chang H, Lovitch SB, Horak C, Weber JS, Weirather JL, Wolchok JD, Postow MA, Pavlick AC, Chesney J, Hodi FS. Rodig SJ, et al. Among authors: weber js. Sci Transl Med. 2018 Jul 18;10(450):eaar3342. doi: 10.1126/scitranslmed.aar3342. Sci Transl Med. 2018. PMID: 30021886 Clinical Trial.

6

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

Chat V, Ferguson R, Simpson D, Kazlow E, Lax R, Moran U, Pavlick A, Frederick D, Boland G, Sullivan R, Ribas A, Flaherty K, Osman I, Weber J, Kirchhoff T. Chat V, et al. Cancer Immunol Immunother. 2019 Jun;68(6):897-905. doi: 10.1007/s00262-019-02318-8. Epub 2019 Mar 12. Cancer Immunol Immunother. 2019. PMID: 30863922 Free PMC article.

7

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients.

Donnelly D, Bajaj S, Yu J, Hsu M, Balar A, Pavlick A, Weber J, Osman I, Zhong J. Donnelly D, et al. J Immunother Cancer. 2019 Aug 19;7(1):222. doi: 10.1186/s40425-019-0699-5. J Immunother Cancer. 2019. PMID: 31426863 Free PMC article.

8

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.

Peters BA, Wilson M, Moran U, Pavlick A, Izsak A, Wechter T, Weber JS, Osman I, Ahn J. Peters BA, et al. Among authors: weber js. Genome Med. 2019 Oct 9;11(1):61. doi: 10.1186/s13073-019-0672-4. Genome Med. 2019. PMID: 31597568 Free PMC article.

9

Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

Bajaj S, Donnelly D, Call M, Johannet P, Moran U, Polsky D, Shapiro R, Berman R, Pavlick A, Weber J, Zhong J, Osman I. Bajaj S, et al. J Natl Cancer Inst. 2020 Sep 1;112(9):921-928. doi: 10.1093/jnci/djaa008. J Natl Cancer Inst. 2020. PMID: 31977051 Free PMC article.

10

Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis.

Efuni E, Cytryn S, Boland P, Niewold TB, Pavlick A, Weber J, Sandigursky S. Efuni E, et al. J Clin Rheumatol. 2021 Oct 1;27(7):267-271. doi: 10.1097/RHU.0000000000001314. J Clin Rheumatol. 2021. PMID: 31977647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page